Global Oncolytic Virus Immunotherapy Market Insight 2020, Forecast to 2025

June 2020 | 115 pages | ID: G358A8563ABBEN
WKinformation

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The Oncolytic Virus Immunotherapy market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Oncolytic Virus Immunotherapy is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.

The report offers detailed coverage of Oncolytic Virus Immunotherapy industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Oncolytic Virus Immunotherapy by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Oncolytic Virus Immunotherapy market are discussed.

The market is segmented by types:

• Engineering Oncolytic Viruses
• Wild-Type Oncolytic Viruses

It can be also divided by applications:

• Hospitals
• Clinics
• Ambulatory Surgical Centers

And this report covers the historical situation, present status and the future prospects of the global Oncolytic Virus Immunotherapy market for 2015-2025. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America.

Finally, the report provides detailed profile and data information analysis of leading company.

• Merck
• Amgen
• TILT Biotherapeutics
• Oncorus
• Sorrento Therapeutics
• Shanghai Sunway Biotech

Report Includes:

• xx data tables and xx additional tables
• An overview of global Oncolytic Virus Immunotherapy market
• An detailed key players analysis across regions
• Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
• Insights into regulatory and environmental developments
• Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Oncolytic Virus Immunotherapy market
• Profiles of major players in the industry, including Merck, Amgen, TILT Biotherapeutics, Oncorus, Sorrento Therapeutics.....

Research objectives

• To study and analyze the global Oncolytic Virus Immunotherapy consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.
• To understand the structure of Oncolytic Virus Immunotherapy market by identifying its various subsegments.
• Focuses on the key global Oncolytic Virus Immunotherapy manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
• To analyze the Oncolytic Virus Immunotherapy with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Oncolytic Virus Immunotherapy submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

Global Oncolytic Virus Immunotherapy Market Report 2020, Forecast to 2025

1 SCOPE OF THE STUDY

1.1 Oncolytic Virus Immunotherapy Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives

2 ONCOLYTIC VIRUS IMMUNOTHERAPY INDUSTRY OVERVIEW

2.1 Global Oncolytic Virus Immunotherapy Market Size (Million USD) Comparison by Regions (2020-2025)
  2.1.1 Oncolytic Virus Immunotherapy Global Main Region Market Analysis
2.2 Market Analysis by Type
  2.2.1 Engineering Oncolytic Viruses
  2.2.2 Wild-Type Oncolytic Viruses
2.3 Market Analysis by Application
  2.3.1 Hospitals
  2.3.2 Clinics
  2.3.3 Ambulatory Surgical Centers
2.4 Global Oncolytic Virus Immunotherapy Revenue, Sales and Market Share by Manufacturer
  2.4.1 Global Oncolytic Virus Immunotherapy Sales and Market Share by Manufacturer (2018-2020)
  2.4.2 Global Oncolytic Virus Immunotherapy Revenue and Market Share by Manufacturer (2018-2020)
  2.4.3 Global Oncolytic Virus Immunotherapy Industry Concentration Ratio (CR5 and HHI)
  2.4.4 Top 5 Oncolytic Virus Immunotherapy Manufacturer Market Share
  2.4.5 Top 10 Oncolytic Virus Immunotherapy Manufacturer Market Share
  2.4.6 Date of Key Manufacturers Enter into Oncolytic Virus Immunotherapy Market
  2.4.7 Key Manufacturers Oncolytic Virus Immunotherapy Product Offered
  2.4.8 Mergers & Acquisitions Planning
2.5 Oncolytic Virus Immunotherapy Historical Development Overview
2.6 Market Dynamics
  2.6.1 Market Opportunities
  2.6.2 Market Risk
  2.6.3 Market Driving Force
  2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): Oncolytic Virus Immunotherapy Industry Impact
  2.7.1 How the Covid-19 is Affecting the Oncolytic Virus Immunotherapy Industry
  2.7.2 Oncolytic Virus Immunotherapy Business Impact Assessment - Covid-19
  2.7.3 Market Trends and Oncolytic Virus Immunotherapy Potential Opportunities in the COVID-19 Landscape
  2.7.4 Measures / Proposal against Covid-19

3 RELATED MARKET ANALYSIS

3.1 Related Market Overview
3.2 Macro Analysis of Upstream Markets
3.3 Key Players in Related Markets
3.4 Related Markets Trend Analysis

4 GLOBAL ONCOLYTIC VIRUS IMMUNOTHERAPY MARKET SIZE CATEGORIZED BY REGIONS

4.1 Global Oncolytic Virus Immunotherapy Revenue and Market Share by Regions
  4.1.1 Global Oncolytic Virus Immunotherapy Sales and Market Share by Regions (2015-2020)
  4.1.2 Global Oncolytic Virus Immunotherapy Revenue and Market Share by Regions (2015-2020)
4.2 Europe Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
4.3 APAC Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
4.4 North America Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
4.5 South America Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)

5 EUROPE ONCOLYTIC VIRUS IMMUNOTHERAPY MARKET SIZE CATEGORIZED BY COUNTRIES

5.1 Europe Oncolytic Virus Immunotherapy Revenue and Market Share by Countries
  5.1.1 Europe Oncolytic Virus Immunotherapy Revenue by Countries (2015-2020)
  5.1.2 Germany Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
  5.1.3 UK Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
  5.1.4 France Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
  5.1.5 Russia Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
  5.1.6 Italy Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
  5.1.7 Spain Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
5.2 Europe Oncolytic Virus Immunotherapy Revenue (Value) by Manufacturers (2018-2020)
5.3 Europe Oncolytic Virus Immunotherapy Revenue and Market Share by Type (2015-2020)
5.4 Europe Oncolytic Virus Immunotherapy Revenue and Market Share by Application (2015-2020)

6 ASIA-PACIFIC ONCOLYTIC VIRUS IMMUNOTHERAPY MARKET SIZE CATEGORIZED BY COUNTRIES

6.1 Asia-Pacific Oncolytic Virus Immunotherapy Revenue and Market Share by Countries
  6.1.1 Asia-Pacific Oncolytic Virus Immunotherapy Revenue by Countries (2015-2020)
  6.1.2 China Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
  6.1.3 Japan Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
  6.1.4 Korea Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
  6.1.5 India Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
  6.1.6 Southeast Asia Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
  6.1.7 Australia Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
6.2 Asia-Pacific Oncolytic Virus Immunotherapy Revenue (Value) by Players (2018-2020)
6.3 Asia-Pacific Oncolytic Virus Immunotherapy Revenue and Market Share by Type (2015-2020)
6.4 Asia-Pacific Oncolytic Virus Immunotherapy Revenue and Market Share by Application (2015-2020)

7 NORTH AMERICA ONCOLYTIC VIRUS IMMUNOTHERAPY MARKET SIZE CATEGORIZED BY COUNTRIES

7.1 North America Oncolytic Virus Immunotherapy Revenue and Market Share by Countries
  7.1.1 North America Oncolytic Virus Immunotherapy Revenue by Countries (2015-2020)
  7.1.2 United States Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
  7.1.3 Canada Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
  7.1.4 Mexico Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
7.2 North America Oncolytic Virus Immunotherapy Revenue (Value) by Players (2018-2020)
7.3 North America Oncolytic Virus Immunotherapy Revenue and Market Share by Type (2015-2020)
7.4 North America Oncolytic Virus Immunotherapy Revenue and Market Share by Application (2015-2020)

8 SOUTH AMERICA ONCOLYTIC VIRUS IMMUNOTHERAPY MARKET SIZE CATEGORIZED BY COUNTRIES

8.1 South America Oncolytic Virus Immunotherapy Revenue and Market Share by Countries
  8.1.1 South America Oncolytic Virus Immunotherapy Revenue by Countries (2015-2020)
  8.1.2 Brazil Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
8.2 South America Oncolytic Virus Immunotherapy Revenue (Value) by Players (2018-2020)
8.3 South America Oncolytic Virus Immunotherapy Revenue and Market Share by Type (2015-2020)
8.4 South America Oncolytic Virus Immunotherapy Revenue and Market Share by Application (2015-2020)

9 MIDDLE EAST AND AFRICA ONCOLYTIC VIRUS IMMUNOTHERAPY MARKET SIZE CATEGORIZED BY COUNTRIES

9.1 Middle East and Africa Oncolytic Virus Immunotherapy Revenue and Market Share by Countries
  9.1.1 Middle East and Africa Oncolytic Virus Immunotherapy Revenue by Countries (2015-2020)
  9.1.2 GCC Countries Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
  9.1.3 Turkey Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
  9.1.4 Egypt Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
  9.1.5 South Africa Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
9.2 Middle East and Africa Oncolytic Virus Immunotherapy Revenue (Value) by Players (2018-2020)
9.3 Middle East and Africa Oncolytic Virus Immunotherapy Revenue and Market Share by Type (2015-2020)
9.4 Middle East and Africa Oncolytic Virus Immunotherapy Revenue and Market Share by Application (2015-2020)

10 GLOBAL ONCOLYTIC VIRUS IMMUNOTHERAPY MARKET SEGMENT BY TYPE

10.1 Global Oncolytic Virus Immunotherapy Revenue and Market Share by Type (2015-2020)
10.2 Global Oncolytic Virus Immunotherapy Market Forecast by Type (2020-2025)
10.3 Engineering Oncolytic Viruses Revenue Growth Rate
10.4 Wild-Type Oncolytic Viruses Revenue Growth Rate

11 GLOBAL ONCOLYTIC VIRUS IMMUNOTHERAPY MARKET SEGMENT BY APPLICATION

11.1 Global Oncolytic Virus Immunotherapy Revenue Market Share by Application (2015-2020)
11.2 Global Oncolytic Virus Immunotherapy Market Forecast by Application (2020-2025)
11.3 Hospitals Revenue Growth Rate (2015-2025)
11.4 Clinics Revenue Growth Rate (2015-2025)
11.5 Ambulatory Surgical Centers Revenue Growth Rate (2015-2025)

12 MARKET FORECAST FOR ONCOLYTIC VIRUS IMMUNOTHERAPY

12.1 Global Oncolytic Virus Immunotherapy Market Size Forecast (2020-2025)
12.2 Oncolytic Virus Immunotherapy Market Forecast by Regions (2020-2025)
12.3 Europe Oncolytic Virus Immunotherapy Revenue Market Forecast (2020-2025)
12.4 APAC Oncolytic Virus Immunotherapy Revenue Market Forecast (2020-2025)
12.5 North America Oncolytic Virus Immunotherapy Revenue Market Forecast (2020-2025)
12.6 South America Oncolytic Virus Immunotherapy Revenue Market Forecast (2020-2025)
12.7 Middle East & Africa Oncolytic Virus Immunotherapy Revenue Market Forecast (2020-2025)

13 ANALYSIS OF ONCOLYTIC VIRUS IMMUNOTHERAPY INDUSTRY KEY VENDORS

13.1 Merck
  13.1.1 Company Details
  13.1.2 Product Information
  13.1.3 Merck Oncolytic Virus Immunotherapy Revenue and Gross Margin (2018-2020)
  13.1.4 Main Business Overview
  13.1.5 Merck News
13.2 Amgen
  13.2.1 Company Details
  13.2.2 Product Information
  13.2.3 Amgen Oncolytic Virus Immunotherapy Revenue and Gross Margin (2018-2020)
  13.2.4 Main Business Overview
  13.2.5 Amgen News
13.3 TILT Biotherapeutics
  13.3.1 Company Details
  13.3.2 Product Information
  13.3.3 TILT Biotherapeutics Oncolytic Virus Immunotherapy Revenue and Gross Margin (2018-2020)
  13.3.4 Main Business Overview
  13.3.5 TILT Biotherapeutics News
13.4 Oncorus
  13.4.1 Company Details
  13.4.2 Product Information
  13.4.3 Oncorus Oncolytic Virus Immunotherapy Revenue and Gross Margin (2018-2020)
  13.4.4 Main Business Overview
  13.4.5 Oncorus News
13.5 Sorrento Therapeutics
  13.5.1 Company Details
  13.5.2 Product Information
  13.5.3 Sorrento Therapeutics Oncolytic Virus Immunotherapy Revenue and Gross Margin (2018-2020)
  13.5.4 Main Business Overview
  13.5.5 Sorrento Therapeutics News
13.6 Shanghai Sunway Biotech
  13.6.1 Company Details
  13.6.2 Product Information
  13.6.3 Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Revenue and Gross Margin (2018-2020)
  13.6.4 Main Business Overview
  13.6.5 Shanghai Sunway Biotech News

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Oncolytic Virus Immunotherapy Picture
Figure Research Programs/Design for This Report
Figure Global Oncolytic Virus Immunotherapy Market by Regions (2019)
Table Global Market Oncolytic Virus Immunotherapy Comparison by Regions (M USD) 2019-2025
Table Global Oncolytic Virus Immunotherapy Value Growth (CAGR) (2019-2025) by Type
Figure Global Value Market Share of Oncolytic Virus Immunotherapy by Type in 2019
Figure Engineering Oncolytic Viruses Picture
Figure Wild-Type Oncolytic Viruses Picture
Table Global Oncolytic Virus Immunotherapy Sales by Application (2019-2025)
Figure Global Oncolytic Virus Immunotherapy Value Market Share by Application in 2019
Figure Hospitals Picture
Figure Clinics Picture
Figure Ambulatory Surgical Centers Picture
Table Global Oncolytic Virus Immunotherapy Revenue by Vendors (2018-2020)
Figure Global Oncolytic Virus Immunotherapy Revenue Market Share by Vendors in 2019
Table Global Oncolytic Virus Immunotherapy Vendors Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Oncolytic Virus Immunotherapy Vendors (Revenue) Market Share in 2019
Figure Top 10 Oncolytic Virus Immunotherapy Vendors (Revenue) Market Share in 2019
Table Date of Key Vendors Enter into Oncolytic Virus Immunotherapy Market
Table Key Vendors Oncolytic Virus Immunotherapy Product Type
Table Mergers & Acquisitions Planning
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Table Key Players of Related Markets
Figure Global Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate (%) (2015-2020)
Table Global Oncolytic Virus Immunotherapy Revenue (Million USD) by Regions (2015-2020)
Table Global Oncolytic Virus Immunotherapy Revenue Market Share by Regions (2015-2020)
Figure Global Oncolytic Virus Immunotherapy Revenue Market Share by Regions in 2019
Figure Europe Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Figure APAC Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Figure North America Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Figure South America Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Figure Middle East & Africa Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Figure Europe Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Table Europe Oncolytic Virus Immunotherapy Revenue by Countries (2015-2020)
Table Europe Oncolytic Virus Immunotherapy Revenue Market Share by Countries (2015-2020)
Figure Europe Oncolytic Virus Immunotherapy Revenue Market Share by Countries in 2019
Figure Germany Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Figure UK Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Figure France Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Figure Russia Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Figure Italy Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Figure Spain Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Table Europe Oncolytic Virus Immunotherapy Revenue by Player (2018-2020)
Figure Europe Oncolytic Virus Immunotherapy Revenue Market Share by Player in 2019
Table Europe Oncolytic Virus Immunotherapy Revenue by Type (2015-2020)
Table Europe Oncolytic Virus Immunotherapy Revenue Share by Type (2015-2020)
Table Europe Oncolytic Virus Immunotherapy Revenue by Application (2015-2020)
Table Europe Oncolytic Virus Immunotherapy Revenue Share by Application (2015-2020)
Figure Asia-Pacific Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Table Asia-Pacific Oncolytic Virus Immunotherapy Revenue by Countries (2015-2020)
Table Asia-Pacific Oncolytic Virus Immunotherapy Revenue Market Share by Countries (2015-2020)
Figure Asia-Pacific Oncolytic Virus Immunotherapy Revenue Market Share by Countries (2015-2020)
Figure Asia-Pacific 115 Revenue Market Share by Countries in 2019
Figure China Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Figure Japan Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Figure Korea Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Figure India Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Figure Australia Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Table Asia-Pacific Oncolytic Virus Immunotherapy Revenue by Player (2018-2020)
Figure Asia-Pacific Oncolytic Virus Immunotherapy Revenue Market Share by Player in 2019
Table Asia-Pacific Oncolytic Virus Immunotherapy Revenue by Type (2015-2020)
Table Asia-Pacific Oncolytic Virus Immunotherapy Revenue Share by Type (2015-2020)
Table Asia-Pacific Oncolytic Virus Immunotherapy Revenue by Application (2015-2020)
Table Asia-Pacific Oncolytic Virus Immunotherapy Revenue Share by Application (2015-2020)
Figure North America Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Table North America Oncolytic Virus Immunotherapy Revenue by Countries (2015-2020)
Table North America Oncolytic Virus Immunotherapy Revenue Market Share by Countries (2015-2020)
Figure North America Oncolytic Virus Immunotherapy Revenue Market Share by Countries in 2019
Figure United States Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Figure Canada Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Figure Mexico Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Table North America Oncolytic Virus Immunotherapy Revenue by Player (2018-2020)
Figure North America Oncolytic Virus Immunotherapy Revenue Market Share by Player in 2019
Table North America Oncolytic Virus Immunotherapy Revenue by Type (2015-2020)
Table North America Oncolytic Virus Immunotherapy Revenue Share by Type (2015-2020)
Table North America Oncolytic Virus Immunotherapy Revenue by Application (2015-2020)
Table North America Oncolytic Virus Immunotherapy Revenue Share by Application (2015-2020)
Figure South America Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Table South America Oncolytic Virus Immunotherapy Revenue by Countries (2015-2020)
Table South America Oncolytic Virus Immunotherapy Revenue Market Share by Countries (2015-2020)
Figure South America Oncolytic Virus Immunotherapy Revenue Market Share by Countries in 2019
Figure Brazil Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Table South America Oncolytic Virus Immunotherapy Revenue by Player (2018-2020)
Figure South America Oncolytic Virus Immunotherapy Revenue Market Share by Manufacturer in 2019
Table South America Oncolytic Virus Immunotherapy Revenue by Type (2015-2020)
Table South America Oncolytic Virus Immunotherapy Revenue Share by Type (2015-2020)
Table South America Oncolytic Virus Immunotherapy Revenue by Application (2015-2020)
Table South America Oncolytic Virus Immunotherapy Revenue Share by Application (2015-2020)
Figure Middle East and Africa Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Table Middle East and Africa Oncolytic Virus Immunotherapy Revenue by Countries (2015-2020)
Table Middle East and Africa Oncolytic Virus Immunotherapy Revenue Market Share by Countries (2015-2020)
Figure Middle East and Africa Oncolytic Virus Immunotherapy Sales Market Share by Countries in 2019
Figure Middle East and Africa Oncolytic Virus Immunotherapy Revenue Market Share by Countries in 2019
Figure GCC Countries Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Figure Egypt Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Figure Turkey Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Figure South Africa Oncolytic Virus Immunotherapy Revenue and Growth Rate (2015-2020)
Table Middle East and Africa Oncolytic Virus Immunotherapy Revenue by Player (2018-2020)
Figure Middle East and Africa Oncolytic Virus Immunotherapy Revenue Market Share by Player in 2019
Table Middle East and Africa Oncolytic Virus Immunotherapy Revenue by Type (2015-2020)
Table Middle East and Africa Oncolytic Virus Immunotherapy Revenue Share by Type (2015-2020)
Table Middle East and Africa Oncolytic Virus Immunotherapy Revenue by Application (2015-2020)
Table Middle East and Africa Oncolytic Virus Immunotherapy Revenue Share by Application (2015-2020)
Table Global Oncolytic Virus Immunotherapy Revenue (Million USD) by Type (2015-2020)
Table Global Oncolytic Virus Immunotherapy Revenue Share by Type (2015-2020)
Figure Global Oncolytic Virus Immunotherapy Revenue Share by Type (2015-2020)
Figure Global Oncolytic Virus Immunotherapy Revenue Share by Type in 2019
Table Global Oncolytic Virus Immunotherapy Revenue Forecast by Type (2020-2025)
Figure Global Oncolytic Virus Immunotherapy Market Share Forecast by Type (2020-2025)
Figure Global Engineering Oncolytic Viruses Revenue Growth Rate (2015-2025)
Figure Global Wild-Type Oncolytic Viruses Revenue Growth Rate (2015-2025)
Table Global Oncolytic Virus Immunotherapy Revenue by Application (2015-2020)
Table Global Oncolytic Virus Immunotherapy Revenue Share by Application (2015-2020)
Figure Global Oncolytic Virus Immunotherapy Revenue Share by Application (2015-2020)
Figure Global Oncolytic Virus Immunotherapy Revenue Share by Application in 2019
Figure Global Oncolytic Virus Immunotherapy Revenue Forecast by Application (2020-2025)
Figure Global Oncolytic Virus Immunotherapy Market Share Forecast by Application (2020-2025)
Figure Global Hospitals Revenue Growth Rate (2015-2025)
Figure Global Clinics Revenue Growth Rate (2015-2025)
Figure Global Ambulatory Surgical Centers Revenue Growth Rate (2015-2025)
Figure Global Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate Forecast (2020-2025)
Figure Global Oncolytic Virus Immunotherapy Revenue (Million USD) Forecast by Regions (2020-2025)
Figure Global Oncolytic Virus Immunotherapy Revenue Market Share Forecast by Regions (2020-2025)
Figure Europe Oncolytic Virus Immunotherapy Revenue Market Forecast (2020-2025)
Figure Asia-Pacific Oncolytic Virus Immunotherapy Revenue Market Forecast (2020-2025)
Figure North America Oncolytic Virus Immunotherapy Revenue Market Forecast (2020-2025)
Figure South America Oncolytic Virus Immunotherapy Revenue Market Forecast (2020-2025)
Figure Middle East and Africa Oncolytic Virus Immunotherapy Revenue Market Forecast (2020-2025)
Table Merck Company Profile
Figure Oncolytic Virus Immunotherapy Product Picture and Specifications of Merck
Table Oncolytic Virus Immunotherapy Revenue (M USD) and Gross Margin 2018-2020
Figure Merck Oncolytic Virus Immunotherapy Market Share (2018-2020)
Table Merck Main Business
Table Merck Recent Development
Table Amgen Company Profile
Figure Oncolytic Virus Immunotherapy Product Picture and Specifications of Amgen
Table Oncolytic Virus Immunotherapy Revenue (M USD) and Gross Margin 2018-2020
Figure Amgen Oncolytic Virus Immunotherapy Market Share (2018-2020)
Table Amgen Main Business
Table Amgen Recent Development
Table TILT Biotherapeutics Company Profile
Figure Oncolytic Virus Immunotherapy Product Picture and Specifications of TILT Biotherapeutics
Table Oncolytic Virus Immunotherapy Revenue (M USD) and Gross Margin 2018-2020
Figure TILT Biotherapeutics Oncolytic Virus Immunotherapy Market Share (2018-2020)
Table TILT Biotherapeutics Main Business
Table TILT Biotherapeutics Recent Development
Table Oncorus Company Profile
Figure Oncolytic Virus Immunotherapy Product Picture and Specifications of Oncorus
Table Oncolytic Virus Immunotherapy Revenue (M USD) and Gross Margin 2018-2020
Figure Oncorus Oncolytic Virus Immunotherapy Market Share (2018-2020)
Table Oncorus Main Business
Table Oncorus Recent Development
Table Sorrento Therapeutics Company Profile
Figure Oncolytic Virus Immunotherapy Product Picture and Specifications of Sorrento Therapeutics
Table Oncolytic Virus Immunotherapy Revenue (M USD) and Gross Margin 2018-2020
Figure Sorrento Therapeutics Oncolytic Virus Immunotherapy Market Share (2018-2020)
Table Sorrento Therapeutics Main Business
Table Sorrento Therapeutics Recent Development
Table Shanghai Sunway Biotech Company Profile
Figure Oncolytic Virus Immunotherapy Product Picture and Specifications of Shanghai Sunway Biotech
Table Oncolytic Virus Immunotherapy Revenue (M USD) and Gross Margin 2018-2020
Figure Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Market Share (2018-2020)
Table Shanghai Sunway Biotech Main Business
Table Shanghai Sunway Biotech Recent Development